Eliem Therapeutics (ELYM) Insider Trading & Ownership $2.34 -0.08 (-3.31%) (As of 12/17/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Eliem Therapeutics (NASDAQ:ELYM) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.70%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$49.95 MNumber OfInsiders Selling(Last 12 Months)2Amount OfInsider Selling(Last 12 Months)$2.15 M Get ELYM Insider Trade Alerts Want to know when executives and insiders are buying or selling Eliem Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ELYM Insider Buying and Selling by Quarter Ad True Market InsidersHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 different coins that have returned over 100%... But today, Chris is now making the biggest crypto call of his ENTIRE career…#1 FREE Crypto for 2024 Eliem Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/20/2024Emily PimblettCAOSell1,191$8.18$9,742.38 7/22/2024Valerie MorissetEVPSell69,005$8.03$554,110.15 7/19/2024Valerie MorissetEVPSell60,201$7.21$434,049.21 7/17/2024Valerie MorissetEVPSell3,207$6.91$22,160.37 7/15/2024Valerie MorissetEVPSell42,377$7.01$297,062.77 7/11/2024Valerie MorissetEVPSell50,000$7.11$355,500.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 7/9/2024Valerie MorissetEVPSell5,931$6.66$39,500.46 7/5/2024Valerie MorissetEVPSell12,342$7.06$87,134.52 7/3/2024Valerie MorissetEVPSell50,000$6.76$338,000.00 6/27/2024Ra Capital Management, L.P.DirectorBuy13,008,546$3.84$49,952,816.64 6/20/2024Emily PimblettCAOSell1,245$7.21$8,976.45 (Data available from 1/1/2013 forward) ELYM Insider Trading Activity - Frequently Asked Questions Who is on Eliem Therapeutics's Insider Roster? The list of insiders at Eliem Therapeutics includes Emily Pimblett, Ra Capital Management, L.P., and Valerie Morisset. Learn more on insiders at ELYM. What percentage of Eliem Therapeutics stock is owned by insiders? 4.70% of Eliem Therapeutics stock is owned by insiders. Learn more on ELYM's insider holdings. Which Eliem Therapeutics insiders have been buying company stock? The following insider purchased ELYM shares in the last 24 months: Ra Capital Management, L.P. ($49,952,816.64). How much insider buying is happening at Eliem Therapeutics? Insiders have purchased a total of 13,008,546 ELYM shares in the last 24 months for a total of $49,952,816.64 bought. Which Eliem Therapeutics insiders have been selling company stock? The following insiders have sold ELYM shares in the last 24 months: Emily Pimblett ($18,718.83), and Valerie Morisset ($2,127,517.48). How much insider selling is happening at Eliem Therapeutics? Insiders have sold a total of 295,499 Eliem Therapeutics shares in the last 24 months for a total of $2,146,236.31 sold. Eliem Therapeutics Key ExecutivesDr. Andrew Levin M.D. (Age 46)Ph.D., Principal Financial Officer & Executive Chairman Compensation: $73kDr. Valerie Morisset Ph.D. (Age 54)Chief Scientific Officer and Executive VP of Research & Development Compensation: $617.87kMs. Emily Pimblett (Age 40)Principal Accounting Officer 2 recent tradesMs. Jo Palmer-Phillips Ph.D.Chief Development Officer More Insider Trading Tools from MarketBeat Related Companies 4D Molecular Therapeutics Insider Selling C4 Therapeutics Insider Selling Larimar Therapeutics Insider Selling Benitec Biopharma Insider Selling COMPASS Pathways Insider Selling Foghorn Therapeutics Insider Selling Amylyx Pharmaceuticals Insider Selling Lifecore Biomedical Insider Selling iTeos Therapeutics Insider Selling Eledon Pharmaceuticals Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles AppLovin Insiders Sell Shares: Stock Price Indicated Higher Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the MillionsInsiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidZeta Global Holdings Insiders Buy Stock After Short-Report This page (NASDAQ:ELYM) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersTrump’s Secret Manhattan ProjectOn January 20, a whole new Manhattan Project is set to begin: Trump’s Manhattan Project. Folks, I just s...Banyan Hill Publishing | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | SponsoredWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Behind the Markets | SponsoredMissed Nvidia? Buy Elon Musk’s “Silent Partner”In February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my f...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eliem Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Eliem Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
